Brian Gilhuly

Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut.

P2 Science, Inc. operates as a specialty chemical biorefinery company. It offers cosmetics and personal care, flavors and fragrances, specialty materials, and bioactives. The company was founded by Neil A. Burns, Paul Anastas, and Patrick Foley in 2011 and is headquartered in Woodbridge, CT.

Tangen Biosciences, Inc. develops portable instruments and methods for use in molecular diagnostics. Its instrument provides rapid nucleic acid detection, with the specificity and sensitivity of polymerase chain reaction amplification. The company was founded by John R. Nobile and John Davidson in 2013 and is headquartered in Branford, CT.

EpiEP, Inc. develops heart-related medical devices. It has developed epicardial access system, EpiAccess, which engages a patent protected pressure-guided needle that is designed to alert physicians of needle tip location during epicardial access procedures. The firm specializes on instruments that facilitates an epicardial approach for patients who benefit from minimally invasive procedures on the surface of the heart. The company was founded by Pamela M. Bunes, Jason Tucker-Schwartz, Srijoy Mahapatra and George T. Gillies in December 2008 and is headquartered in New Haven, CT.

FMP Products, Inc. designs, manufactures and sells laboratory automation equipment to pharmaceutical companies. Its products include 3D digital video microscope with automated xyz stage and servo controlled micro manipulators. The company was founded by Thomas J. Friedlander And Walter Meltzer in 2005 and is headquartered in Danbury, CT.

CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT.

BioRez, Inc. engages in the design and development of resorbable polymer scaffold technology. The firm offers a device that is suited for tendon, ligament, and other soft tissue injuries. The company was founded by Cato T. Laurencin and Joseph W. Reilly in 2008 and is headquartered in New Haven, CT.

New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT.

Synbody Biotechnology, Inc. operates as a platform for the discovery and development of novel and attractive molecules. The company was founded by Paul L. Hallenbeck, Chris Diehnelt, Kevin D. Burroughs and Stephen Albert Johnston in 2010 and is headquartered in Chester Springs, PA.

AlloMek Therapeutics LLC develops and discovers pharmaceutical products for cancer therapies. It offers MEK kinase inhibitors that improve the biopharmaceutical properties of previous MEK inhibitors. The company was founded by Khire R. Uday and Barry Hart in 2010 and is headquartered in Farmington, CT.